References
- Whitmore A, Krishnaswami CS. An account of the discovery of a hitherto undiscovered infective disease occurring among the population of Rangoon. Indian Med Gaz 1912; 47: 262–7
- Pathogenesis and Virulence: Invasion and intracellular survival. In: Puthucheary SD Vadivelu J, Human Melioidosis. Singapore: Singapore University Press; 2002. p. 28–32.
- Principles of Management. In: Puthucheary SD, Vadivelu J Human Melioidosis. Singapore: Singapore University Press; 2002. p. 56–63.
- Puthucheary SD, Parasakthi N. Susceptibility of 57 strains of Pseudomallei to some new β-lactams and other antibiotics. Med J Malaysia 1987; 42: 248–51
- White NJ, Dance DA, Chaowagul W, Wattanagoon Y, Wuthiekanun V, Pitakwachara N. Halving of mortality of severe melioidosis by ceftazidime. Lancet 1989; 2: 697–701
- Dance DA, Wuthiekanun V, Chaowagul W, White NJ. The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment. J Antimicrob Chemother 1989; 24: 295–309
- Thibault FM, Hernandez E, Vidal DR, Girardet M, Cavallo JD. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. J Antimicrob Chemother 2004; 54: 1134–8
- Chierakul W, Anunnatsiri S, Short JM, Maharjan B, Mootsikapun P, Simpson AJ, et al. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis. Clin Infect Dis 2005; 41: 1105–13
- Inglis TJ, Rodrigues F, Rigby P, Norton R, Currie BJ. Comparison of the susceptibilities of Burkholderia pseudomallei to meropenem and ceftazidime by conventional and intracellular methods. Antimicrob Agents Chemother 2004; 48: 2999–3005
- Simpson AJ, Suputtamongkol Y, Smith MD, Angus BJ, Rajanuwong A, Wuthiekanun V, et al. Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin Infect Dis 1999; 29: 381–7
- Vorachit M, Chongtrakool P, Arkomsean S, Boonsong S. Antimicrobial resistance in Burkholderia pseudomallei. Acta Trop 2000; 74: 139–44
- Steward J, Piercy T, Lever MS, Nelson M, Simpson AJ, Brooks TJ. Comparison of gatifloxacin, moxifloxacin and ciprofloxacin for treatment of experimental Burkholderia pseudomallei infection. J Antimicrob Chemother 2005; 55: 523–7
- Lee SW, Yi J, Joo SI, Kang YA, Yoon YS, Yim JJ, et al. A case of melioidosis presenting as migrating pulmonary infiltration: the first case in Korea. J Korean Med Sci 2005; 20: 139–42
- Hsueh P-R, Teng L-J, Lee L-N, Yu C-R, Yang P-C, Ho S-W, et al. Melioidosis: an emerging infection in Taiwan?. Emerg Infect Dis 2001; 7: 428–33
- Clinical and Laboratory Standards Institute (CLSI) January, 2006. Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth informational supplement M100-S16. Vol. 26, No. 3.
- BSAC Methods for Antimicrobial Susceptibility testing, Version 5, January, 2006. Available at http://www.bsac.org.uk/_db/_documents/version_5_.pdf.
- Smith MD, Wuthiekanun V, Walsh AL, White NJ. In vitro activity of carbapenem antibiotics against beta-lactam susceptible and resistant strains of Burkholderia pseudomallei. J Antimicrob Chemother 1996; 37: 611–5
- Minassian MA, Gage A, Price E, Sefton AM. Imipenem for the treatment of melioidosis. Int J Antimicrob Agents 1999; 12: 263–5
- Sivalingam PS, Sim SH, Aw LT, Ooi EE. Antibiotic susceptibility of 50 clinical isolates of Burkholderia pseudomallei from Singapore. J Antimicrob Chemother 2006; 58: 1102–3
- Wuthiekanun V, Cheng AC, Chierakul W, Amornchai P, Limmathurotsakul D, Chaowagul W, et al. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei. J Antimicrob Chemother 2005; 55: 1029–31
- Cheong YM, Joseph PG, Koay AS. In vitro susceptibility of Pseudomonas pseudomallei isolated in Malaysia to some new cephalosporins and a quinolone. Southeast Asian J Trop Med Pub Health 1987; 18: 94–6
- van der Auwera P, Matsumoto T, Husson M. Intraphagocytic penetration by antibiotics. J Antimicrob Chemother 1988; 22: 185–92
- Chaowagul W, Suputtamongkol Y, Smith MD, White NJ. Oral fluoroquinolones for maintenance treatment of melioidosis. Trans Roy Soc Trop Med Hyg 1997; 91: 599–601
- Vorachit M, Lam K, Jayanetra P, Costerton JW. Electron microscopy study of the mode of growth of Pseudomonas pseudomallei in vitro. J Trop Med Hyg 1995; 98: 379–91